Gene Therapy Market (2nd Edition), 2018-2030

Steffan98702 Jul, 2021Health

Around 300 product candidates are currently under various stages of development for a diverse range of indications. Eight gene therapies are commercially available; of these, Imlygic? (Amgen), Strimvelis? (GSK), Invossa? (TissueGene / Kolon Life Science / Mitsubishi Tanabe Pharma) and Luxturna? (Spark Therapeutics) were approved after 2015